Gainers

• Replimune Group (NASDAQ:REPL) shares increased by 134.6% to $12.69 during Friday's pre-market session.
• Moleculin Biotech (NASDAQ:MBRX) shares increased by 17.64% to $1.2. The market value of their outstanding shares is at $5.4 million.
• Cuprina Holdings (Cayman) (NASDAQ:CUPR) stock increased by 13.72% to $3.02. The company's market cap stands at $7.1 million.
• Polaryx Therapeutics (NASDAQ:PLYX) stock moved upwards by 11.62% to $2.4. The company's market cap stands at $107.1 million.
• VivoSim Labs (NASDAQ:VIVS) stock moved upwards by 11.32% to $0.43. The company's market cap stands at $1.3 million.
• BioRestorative Therapies (NASDAQ:BRTX) shares rose 10.42% to $0.25. The company's market cap stands at $5.7 million.

Losers

• Karyopharm Therapeutics (NASDAQ:KPTI) stock declined by 69.6% to $2.13 during Friday's pre-market session. The market value of their outstanding shares is at $158.8 million.
• Bioage Labs (NASDAQ:BIOA) shares declined by 53.0% to $11.68. The market value of their outstanding shares is at $1.1 billion.
• Nuwellis (NASDAQ:NUWE) shares fell 39.33% to $2.7.
• Myriad Genetics (NASDAQ:MYGN) stock fell 37.81% to $3.34. The company's market cap stands at $507.1 million. As per the news, the Q2 earnings report came out yesterday.
• Monte Rosa Therapeutics (NASDAQ:GLUE) stock declined by 27.03% to $16.55. The market value of their outstanding shares is at $1.9 billion.
• AirSculpt Technologies (NASDAQ:AIRS) shares fell 17.53% to $4.0. The market value of their outstanding shares is at $342.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.